Literature DB >> 34813001

The regulatory effects of clomiphene and tamoxifen on mTOR and LC3-II expressions in relation to autophagy in experimental polycystic ovary syndrome (PCOS).

Gökçe Ceren Kuşçu1, Çevik Gürel1,2, Aylin Buhur1, Fatih Oltulu1, Levent Akman3, Timur Köse4, Nefise Ülkü Karabay Yavaşoğlu5, Altuğ Yavaşoğlu1.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a metabolic disease that causes infertility due to anovulation in women in reproductive age. It is known that clomiphene citrate (CC) and tamoxifen citrate (TMX) induce ovulation in women with PCOS. In this study, we aimed to investigate the effects of CC and TMX on the autophagy pathway in PCOS. METHODS AND
RESULTS: Experimental PCOS model was induced by letrozole (1 mg/kg) in rats by gavage for 21 days. After the last letrozole administration, rats were treated TMX (1 mg/kg) or CC (1 mg/kg) for 5 days. At the end of the experimental procedures, rats in all groups were sacrificed and ovarian tissues were removed. It was observed that mRNA and protein expressions of LC3-II were significantly higher in TMX and CC groups than control and PCOS groups (p < 0.05), while mRNA and protein expressions of mTOR in TMX and CC groups were found significantly lower than control and PCOS groups (p < 0.05).
CONCLUSIONS: In conclusion, present study suggests that TMX and CC induce autophagy in ovaries with PCOS. Autophagy is a promising target for understanding pathophysiology of this disease and for developing more effective and safe new protocols for the treatment of PCOS-related anovulation.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Autophagy; Clomiphene; LC3-II; PCOS; Tamoxifen; mTOR

Mesh:

Substances:

Year:  2021        PMID: 34813001     DOI: 10.1007/s11033-021-06981-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

1.  Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer.

Authors:  Chandan Kanta Das; Aditya Parekh; Pratap Kumar Parida; Sujit Kumar Bhutia; Mahitosh Mandal
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-03-13       Impact factor: 4.739

2.  Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling during the development of polycystic ovary syndrome.

Authors:  Mutsumi Kobayashi; Osamu Yoshino; Akitoshi Nakashima; Masami Ito; Kazuyuki Nishio; Yosuke Ono; Tae Kusabiraki; Chisato Kunitomi; Nozomi Takahashi; Miyuki Harada; Katsushige Hattori; Makoto Orisaka; Yutaka Osuga; Shigeru Saito
Journal:  Mol Cell Endocrinol       Date:  2020-03-19       Impact factor: 4.102

Review 3.  Ovulation induction in the management of anovulatory polycystic ovary syndrome.

Authors:  Adam H Balen
Journal:  Mol Cell Endocrinol       Date:  2012-10-17       Impact factor: 4.102

Review 4.  Endocrine Therapy for Early Breast Cancer: Updated Review.

Authors:  Alexander Tremont; Jonathan Lu; John T Cole
Journal:  Ochsner J       Date:  2017

5.  RETRACTED: Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS: a prospective randomized trial

Authors:  Ahmed Badawy; Ahmed Gibreal
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-08-09       Impact factor: 2.831

Review 6.  Precautions for Patients Taking Tamoxifen.

Authors:  Mary Heery; Patrick Corbett; Richard Zelkowitz
Journal:  J Adv Pract Oncol       Date:  2018-01-01

7.  Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome.

Authors:  Krutika Patil; Soujanya Yelamanchi; Manish Kumar; Indira Hinduja; T S Keshava Prasad; Harsha Gowda; Srabani Mukherjee
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

8.  Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.

Authors:  M F Costello; M L Misso; A Balen; J Boyle; L Devoto; R M Garad; R Hart; L Johnson; C Jordan; R S Legro; R J Norman; E Mocanu; J Qiao; R J Rodgers; L Rombauts; E C Tassone; S Thangaratinam; E Vanky; H J Teede
Journal:  Hum Reprod Open       Date:  2019-01-04

Review 9.  Estrogen Receptors in Polycystic Ovary Syndrome.

Authors:  Xue-Ling Xu; Shou-Long Deng; Zheng-Xing Lian; Kun Yu
Journal:  Cells       Date:  2021-02-21       Impact factor: 6.600

10.  Usefulness of intermittent clomiphene citrate treatment for women with polycystic ovarian syndrome that is resistant to standard clomiphene citrate treatment.

Authors:  Akihisa Takasaki; Isao Tamura; Maki Okada-Hayashi; Takeshi Orita; Manabu Tanabe; Shoko Maruyama; Katsunori Shimamura; Hitoshi Morioka
Journal:  Reprod Med Biol       Date:  2018-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.